Successful Management of Primary Mediastinal Large B-cell Lymphoma During Pregnancy

Overview

Journal Intern Med

Specialty General Medicine

Date 2019 Aug 9

PMID 31391392

Citations 2

Authors

Yoshinori Hashimoto

Hiromi Omura

Yusuke Tokuyasu

Shu Nakamoto

Takayuki Tanaka

Affiliations

Soon will be listed here.

Abstract

We experienced a pregnant woman with superior vena cava syndrome at 15 weeks of pregnancy who was diagnosed with primary mediastinal large B-cell lymphoma and given chemotherapy. In this case, the clinical courses of both the mother and infant were favorable without any serious complications because of close multidisciplinary cooperation. Based on a retrospective review of this case, the administration of CHOP-like regimens during the second and third trimesters appears relatively safe. Because pregnancy and continuation of pregnancy are rare in patients with hematopoietic malignancies, the accumulation of detailed information is important.

Citing Articles

Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian context.

Cassidy L, Shand A, Said J, Hobbs K, Kidson-Gerber G, Belinda C Intern Med J. 2025; 55(3):393-406.

PMID: 40042130 PMC: 11900863. DOI: 10.1111/imj.16651.

Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy.

Annunzio K, Cackovic M, Bond D, Sawalha Y, Voorhees T, Hanel W Blood Adv. 2022; 7(10):2241-2244.

PMID: 36287222 PMC: 10196908. DOI: 10.1182/bloodadvances.2022008621.

Cancer during Pregnancy: A Review of Preclinical and Clinical Transplacental Transfer of Anticancer Agents.

Benoit L, Mir O, Vialard F, Berveiller P Cancers (Basel). 2021; 13(6).

PMID: 33799824 PMC: 8000411. DOI: 10.3390/cancers13061238.

References

Melani C, Advani R, Roschewski M, Walters K, Chen C, Baratto L . End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making. Haematologica. 2018; 103(8):1337-1344. PMC: 6068044. DOI: 10.3324/haematol.2018.192492. View

Fiascone S, Datkhaeva I, Winer E, Rizack T . Primary mediastinal large B-cell lymphoma in pregnancy. Leuk Lymphoma. 2015; 57(1):240-3. DOI: 10.3109/10428194.2015.1049168. View

Peccatori F, Azim Jr H, Orecchia R, Hoekstra H, Pavlidis N, Kesic V . Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6:vi160-70. DOI: 10.1093/annonc/mdt199. View

Zinzani P, Martelli M, Poletti V, Vitolo U, Gobbi P, Chisesi T . Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental.... Haematologica. 2008; 93(9):1364-71. DOI: 10.3324/haematol.12742. View

Todeschini G, SECCHI S, Morra E, Vitolo U, Orlandi E, Pasini F . Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer. 2004; 90(2):372-6. PMC: 2409547. DOI: 10.1038/sj.bjc.6601460. View

Chakravarty E, Murray E, Kelman A, Farmer P . Pregnancy outcomes after maternal exposure to rituximab. Blood. 2010; 117(5):1499-506. DOI: 10.1182/blood-2010-07-295444. View

Rieger M, Osterborg A, Pettengell R, White D, Gill D, Walewski J . Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol. 2010; 22(3):664-670. DOI: 10.1093/annonc/mdq418. View

Dunleavy K, Pittaluga S, Maeda L, Advani R, Chen C, Hessler J . Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med. 2013; 368(15):1408-16. PMC: 4568999. DOI: 10.1056/NEJMoa1214561. View

Zinzani P, Martelli M, Bertini M, Gianni A, Devizzi L, Federico M . Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica. 2002; 87(12):1258-64. View

10.

Osumi T, Tanaka F, Mori T, Fukano R, Tsurusawa M, Oshima K . Primary mediastinal large B-cell lymphoma in Japanese children and adolescents. Int J Hematol. 2016; 105(4):440-444. DOI: 10.1007/s12185-016-2147-3. View

11.

Khalid S, Khalid A, Daw H, Maroo P . Management of Primary Mediastinal B-Cell Lymphoma in Pregnancy. Cureus. 2018; 10(2):e2215. PMC: 5910010. DOI: 10.7759/cureus.2215. View

12.

Lishner M, Avivi I, Apperley J, Dierickx D, Evens A, Fumagalli M . Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting. J Clin Oncol. 2015; 34(5):501-8. DOI: 10.1200/JCO.2015.62.4445. View

13.

Maeshima A, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N . Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016. Int J Hematol. 2017; 106(5):675-680. DOI: 10.1007/s12185-017-2331-0. View

14.

Giulino-Roth L . How I treat primary mediastinal B-cell lymphoma. Blood. 2018; 132(8):782-790. PMC: 6634954. DOI: 10.1182/blood-2018-04-791566. View

15.

Perez C, Amin J, Aguina L, Cioffi-Lavina M, Santos E . Primary Mediastinal Large B-Cell Lymphoma during Pregnancy. Case Rep Hematol. 2012; 2012:197347. PMC: 3502794. DOI: 10.1155/2012/197347. View

16.

Barth T, Leithauser F, Joos S, Bentz M, Moller P . Mediastinal (thymic) large B-cell lymphoma: where do we stand?. Lancet Oncol. 2002; 3(4):229-34. DOI: 10.1016/s1470-2045(02)00714-3. View

17.

Aoki T, Izutsu K, Suzuki R, Nakaseko C, Arima H, Shimada K . Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan. Haematologica. 2014; 99(12):1817-25. PMC: 4258760. DOI: 10.3324/haematol.2014.111203. View

18.

El-Messidi A, Patenaude V, Abenhaim H . Incidence and outcomes of women with non-Hodgkin's lymphoma in pregnancy: a population-based study on 7.9 million births. J Obstet Gynaecol Res. 2014; 41(4):582-9. DOI: 10.1111/jog.12597. View

19.

Sieber S, Whang-Peng J, Botkin C, Knutsen T . Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. Teratology. 1978; 18(1):31-47. DOI: 10.1002/tera.1420180107. View